Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Changing treatment news

Show

From To
India: SC forces govt to agree to second-line ART to all AIDS patients

NEW DELHI: The Centre on Friday tried everything -- from huge costs to irrational treatment by private hospitals -- to express reservations about extending second-line treatment to all HIV positive patients, but the Supreme Court used the right to life argument to counter them. The government had said it was willing to extend second-line treatment costing Rs 28,500 each to all patients except ...

Published
11 December 2010
From
Times of India
ZAMBIA: Ephraim Banda, The third-line drugs we don't have

LUSAKA, 23 November 2010 (PLUSNEWS) - Before Zambia's public health sector started providing free antiretroviral drugs (ARVs) to people living with HIV, Ephraim Banda bought his own medication. But his supply was often interrupted and the available drugs changed frequently and he is now one of a growing number of HIV-positive Zambians who have developed resistance to both first- and second-line ARV drug regimens.

Published
23 November 2010
From
IRIN Plus News
All HIV patients to get second-line treatment free

All HIV patients put on antiretroviral therapy before 2004 but who became resistant to those drugs will now receive the life saving second line treatment free of cost from the National AIDS Control Organisation (NACO).

Published
13 November 2010
From
Times of India
New computer modelling system predicts responses to HIV and AIDS treatments

HIV-TRePS is a new system that predicts how an HIV patient will respond to different drug regimens, with an accuracy of around 80%. It is free to use, accessed over the Internet, and helps physicians choose the optimum combination of drugs for each patient.

Published
07 October 2010
From
Science Daily
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Generic Version Of Reyataz® Capsules HIV Treatment

Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Atazanavir Sulfate Capsules, 150 mg and 300 mg.

Published
06 October 2010
From
HIV / AIDS News From Medical News Today
ICAAC: Switch to HIV combo pill may improve lipids

Switching from abacavir/3TC/efavirenz to Atripla significantly improved lipids, according to results of a randomised switch study presented at the 50th ICAAC.

Published
16 September 2010
From
MedPage Today
AFRICA/ASIA: Worrying rates of second-line treatment failure

Patients with HIV on second-line antiretroviral (ARV) treatment are significantly more likely to experience treatment failure than those on first-line treatment, according to new research by health NGO Médecins Sans Frontières (MSF).

Published
04 August 2010
From
IRIN Plus News
← Prev1...23456Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.